2-(3-Benzyl-2-oxoquinoxalin-1(2H)-yl)-N'-(4-nitrobenzylidene)acetohydrazide

ID: ALA3408925

Chembl Id: CHEMBL3408925

PubChem CID: 118731271

Max Phase: Preclinical

Molecular Formula: C24H19N5O4

Molecular Weight: 441.45

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(Cn1c(=O)c(Cc2ccccc2)nc2ccccc21)N/N=C/c1ccc([N+](=O)[O-])cc1

Standard InChI:  InChI=1S/C24H19N5O4/c30-23(27-25-15-18-10-12-19(13-11-18)29(32)33)16-28-22-9-5-4-8-20(22)26-21(24(28)31)14-17-6-2-1-3-7-17/h1-13,15H,14,16H2,(H,27,30)/b25-15+

Standard InChI Key:  KYMKWFKRVIGOTL-MFKUBSTISA-N

Alternative Forms

  1. Parent:

    ALA3408925

    ---

Associated Targets(non-human)

MAOA Monoamine oxidase A (484 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAOB Monoamine oxidase B (894 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 441.45Molecular Weight (Monoisotopic): 441.1437AlogP: 3.05#Rotatable Bonds: 7
Polar Surface Area: 119.49Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.63CX Basic pKa: 1.21CX LogP: 3.68CX LogD: 3.68
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.27Np Likeness Score: -1.69

References

1. Khattab SN, Abdel Moneim SA, Bekhit AA, El Massry AM, Hassan SY, El-Faham A, Ali Ahmed HE, Amer A..  (2015)  Exploring new selective 3-benzylquinoxaline-based MAO-A inhibitors: design, synthesis, biological evaluation and docking studies.,  93  [PMID:25707011] [10.1016/j.ejmech.2015.02.020]

Source